Low-Level Expression of Smad7 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Pancreatic Cancer

Peng Wang,Jie Fan,Zhen Chen,Zhi-Qiang Meng,Jian-Min Luo,Jun-Hua Lin,Zhen-Hua Zhou,Hao Chen,Kun Wang,Zu-De Xu,Lu-Ming Liu

DOI: https://doi.org/10.1245/s10434-008-0284-5

IF: 4.339

2009-01-01

Annals of Surgical Oncology

Abstract:Whether Smad7 acts as a tumor proliferation promoting factor or as a metastatic suppressor in human pancreatic cancer remains unclear. This study aims to determine the prognostic value of Smad7 in patients with pancreatic adenocarcinoma.